MDGL
Price
$308.73
Change
+$15.32 (+5.22%)
Updated
Dec 20, 04:59 PM (EDT)
65 days until earnings call
SQZB
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Dec 20 closing price
87 days until earnings call
Ad is loading...

MDGL vs SQZB

Header iconMDGL vs SQZB Comparison
Open Charts MDGL vs SQZBBanner chart's image
Madrigal Pharmaceuticals
Price$308.73
Change+$15.32 (+5.22%)
Volume$11.16K
CapitalizationN/A
SQZ Biotechnologies
Price$0.03
Change-$0.00 (-0.00%)
Volume$6.9K
CapitalizationN/A
MDGL vs SQZB Comparison Chart
Loading...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDGL vs. SQZB commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDGL is a Hold and SQZB is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (MDGL: $308.44 vs. SQZB: $0.03)
Brand notoriety: MDGL and SQZB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDGL: 151% vs. SQZB: 47%
Market capitalization -- MDGL: $6.73B vs. SQZB: $737.28K
MDGL [@Biotechnology] is valued at $6.73B. SQZB’s [@Biotechnology] market capitalization is $737.28K. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDGL’s FA Score shows that 1 FA rating(s) are green whileSQZB’s FA Score has 1 green FA rating(s).

  • MDGL’s FA Score: 1 green, 4 red.
  • SQZB’s FA Score: 1 green, 4 red.
According to our system of comparison, MDGL is a better buy in the long-term than SQZB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDGL’s TA Score shows that 4 TA indicator(s) are bullish while SQZB’s TA Score has 4 bullish TA indicator(s).

  • MDGL’s TA Score: 4 bullish, 4 bearish.
  • SQZB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SQZB is a better buy in the short-term than MDGL.

Price Growth

MDGL (@Biotechnology) experienced а +1.29% price change this week, while SQZB (@Biotechnology) price change was -9.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

MDGL is expected to report earnings on Feb 26, 2025.

SQZB is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($6.73B) has a higher market cap than SQZB($737K). MDGL YTD gains are higher at: 33.305 vs. SQZB (25.628).
MDGLSQZBMDGL / SQZB
Capitalization6.73B737K913,569%
EBITDA-502.65MN/A-
Gain YTD33.30525.628130%
P/E RatioN/AN/A-
Revenue76.8MN/A-
Total Cash999MN/A-
Total Debt119MN/A-
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
30
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
55

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDGLSQZB
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
81%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 6 days ago
88%
View a ticker or compare two or three
Ad is loading...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SQZB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
WDIV62.450.49
+0.80%
SPDR® S&P Global Dividend ETF
MARW31.050.12
+0.40%
AllianzIM U.S. Large Cp Buffer20 Mar ETF
GSST50.400.01
+0.03%
Goldman Sachs Access Ultra Short Bd ETF
ICSH50.36N/A
N/A
iShares Ultra Short-Term Bond Active ETF
VABS24.12-0.01
-0.02%
Virtus Newfleet ABS/MBS ETF

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with KANT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then KANT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
+5.12%
KANT - MDGL
62%
Loosely correlated
-1.83%
VXRT - MDGL
61%
Loosely correlated
+2.70%
ALXO - MDGL
56%
Loosely correlated
+9.46%
REPL - MDGL
55%
Loosely correlated
+4.00%
ZNTL - MDGL
51%
Loosely correlated
+2.39%
More

SQZB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SQZB has been loosely correlated with MDGL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if SQZB jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SQZB
1D Price
Change %
SQZB100%
N/A
MDGL - SQZB
33%
Loosely correlated
+5.12%
ARRY - SQZB
33%
Loosely correlated
+5.43%
AXON - SQZB
33%
Poorly correlated
+2.60%
MIST - SQZB
31%
Poorly correlated
+4.96%
ACHL - SQZB
30%
Poorly correlated
+0.11%
More